Occurrence and Predictors of Spasticity after First-ever Stroke: A Systematic Review
Dilip Maheshwari, Bharat Bhushan, Vijay Sardana, Ravi Goyal, Prashant Shringi
Citation Information :
Maheshwari D, Bhushan B, Sardana V, Goyal R, Shringi P. Occurrence and Predictors of Spasticity after First-ever Stroke: A Systematic Review. Indian J Phy Med Rehab 2020; 31 (3):66-69.
Aim and objective: To review recent studies on occurrence and predictors of post-stroke spasticity (PSS) after first-ever stroke.
Materials and methods: A systematic search of online databases including PubMed, Elsevier, and Springer was performed for literature describing occurrences and predictors of PSS. These data were collected and analyzed.
Results: Nine studies on prevalence including approximately 7,756 participants and 6 studies on predictors of PSS with approximately 755 patients were analyzed. The prevalence of PSS was 7–42% in a maximum 18-month post-stroke follow-up and increased muscle tone, greater severity of paresis, sensory impairment, and low Barthel Index score were predictors of PSS.
Conclusion: Under 65 years of age, patients are more prone to developing PSS, mainly in upper limbs at one year. For the determination of PSS prevalence, multiple parameters of spasticity measurement with biomechanical factors are to be needed. Early advanced rehabilitation, with background knowledge of predictors of PSS, the functional ability can be improved to achieve better outcomes and quality of life.
Hankey GJ. The global and regional burden of stroke. Lancet Glob Health 2013;1(5):e239–e240. DOI: 10.1016/S2214-109X(13)70095-0.
Burridge J, Wood D, Hermens H, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil 2005;27(1-2):69–80. DOI: 10.1080/09638280400014592.
Ashford S, Fheodoroff K, Jacinto J, et al. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis. Clin Rehabil 2016;30(6):617–622. DOI: 10.1177/0269215515593391.
Demetrios M, Khan F, Turner-Stokes L, et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev 2013(6):CD009689. DOI: 10.1002/14651858.CD009689.pub2.
Zorowitz RD, Gillard PJ, Brainin M. Poststroke spasticity: sequelae and burden on stroke survivors and caregivers. Neurology 2013;80(3 Suppl 2):S45–S52. DOI: 10.1212/WNL.0b013e3182764c86.
Lundström E, Smits A, Terént A, et al. Time-course and determinants of spasticity during the first six months following first-ever stroke. J Rehabil Med 2010;42(4):296–301. DOI: 10.2340/16501977-0509.
Lundström E, Terént A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol 2008;15(6):533–539. DOI: 10.1111/j.1468-1331.2008.02114.x.
Sunnerhagen KS. Predictors of spasticity after stroke. Curr Phys Med Rehabil Rep 2016;4(3):182–185. DOI: 10.1007/s40141-016-0128-3.
Urban PP, Wolf T, Uebele M, et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke 2010;41(9):2016–2020. DOI: 10.1161/STROKEAHA.110.581991.
Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol 2010;257(7):1067–1072. DOI: 10.1007/s00415-010-5463-1.
Opheim A, Danielsson A, Alt Murphy M, et al. Upper-limb spasticity during the first year after stroke: stroke arm longitudinal study at the University of Gothenburg. Am J Phys Med Rehabil 2014;93(10):884–896. DOI: 10.1097/PHM.0000000000000157.
Wissel J, Verrier M, Simpson DM, et al. Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PM R 2015;7(1):60–67. DOI: 10.1016/j.pmrj.2014.08.946.
Cacho RO, Cacho EWA, Loureiro AB, et al. Feasibility study onpharmacoeconomics of botulinum toxin A (Botox) in spasticityfollowing stroke. 3rd European Botulinum Toxin Symposium Abstracts 1997;1(4):4. DOI: 10.1590/1980-5918.030.004.ao09.
Sommerfeld DK, Eek EU-B, Svensson A-K, et al. Spasticityafter stroke. Its occurrence and association with motorimpairments and activity limitations. Stroke 2004;35(1):134–139. DOI: 10.1161/01.STR.0000105386.05173.5E.
Welmer AK, von Arbin M, Widén Holmqvist L, et al. Spasticity and its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis 2006;21(4):247–253. DOI: 10.1159/000091222.
Leathley MJ, Gregson JM, Moore AP, et al. Prevalence of spasticity post stroke. Clin Rehabil 2002;16(5):515–522. DOI: 10.1191/0269215502cr512oa.
Leathley MJ, Gregson JM, Moore AP, et al. Predicting spasticity after stroke in those surviving to 12 months. Clin Rehabil 2004;18(4):438–443. DOI: 10.1191/0269215504cr727oa.
O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996;119(Pt 5):1737–1749. DOI: 10.1093/brain/119.5.1737.
Gregson JM, Leathley M, Moore AP, et al. Reliability of the tone assessment scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Arch Phys Med Rehabil 1999;80(9):1013–1016. DOI: 10.1016/s0003-9993(99) 90053-9.
Chung SG, Van Rey EM, Bai Z, et al. Aging-related neuromuscular changes characterized by tendon reflex system properties. Arch Phys Med Rehabil 2005;86(2):318–327. DOI: 10.1016/j.apmr.2004. 04.048.
Dietz V. Human neuronal control of automatic functional movements: interaction between central programs and afferent input. Physiol Rev 1992;72(1):33–69. DOI: 10.1152/physrev.19184.108.40.206.
Yelnik A, Albert T, Bonan I, et al. A clinical guide to assess the role of lower limb extensor overactivity in hemiplegic gait disorders. Stroke 1999;30(3):580–585. DOI: 10.1161/01.STR.30.3.580.
Opheim A, Danielsson A, Alt Murphy M, et al. Early prediction of long-term upper limb spasticity after stroke: part of the SALGOT study. Neurology 2015;85(10):873–880. DOI: 10.1212/WNL.0000000000001908.